Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ranan Gülhan Aktaş"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Three-dimensional (3D) bioprinting culture models capable of reproducing the pathological architecture of diseases are increasingly advancing. In this study, 3D scaffolds were created using extrusion-based bioprinting method with alginate, g
Externí odkaz:
https://doaj.org/article/46b92cd08d3a4a55bbe7f90019ac15a5
Cisplatin, the first platinum compound approved for cancer treatment, is widely used in the treatment of various cancers including hepatocellular carcinoma (HCC). HCC incidence rates rise globally. Epithelial mesenchymal transition (EMT) is implicate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afc70778307869901b120cec0fe31335
https://hdl.handle.net/20.500.12415/10517
https://hdl.handle.net/20.500.12415/10517
Publikováno v:
Türk Üreme Tıbbı ve Cerrahisi Dergisi. 2:93-100
Autor:
Yaprak Donmez Cakil, Zeynep Akbulut, Hatice Maras, Damla Gokceoglu Kayali, Ranan Gulhan Aktas
Publikováno v:
Middle East Journal of Cancer, Vol 13, Iss 1, Pp 89-98 (2022)
Background: The importance of extracellular matrix (ECM) components in the progression of hepatocellular carcinoma (HCC) has been shown in many studies. Although restoring or activating apoptosis in tumors is an active area of cancer research, little
Externí odkaz:
https://doaj.org/article/39394c7c6cd54c198201d5fd90125154
Autor:
Yaprak Donmez Cakil, Zeynep Gunes Ozunal, Damla Gokceoglu Kayali, Ranan Gulhan Aktas, Esra Saglam
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 58 (2023)
Abstract Hepatocellular carcinoma (HCC) is a common cause of cancer-related death. Sorafenib is the first approved drug for the treatment of advanced HCC. Depression is frequent in cancer patients. Moreover, sorafenib might exert depression as an adv
Externí odkaz:
https://doaj.org/article/d69c7f828f6f4463a666e27cef99340f
Publikováno v:
Ulusal travma ve acil cerrahi dergisi = Turkish journal of traumaemergency surgery : TJTES. 15(4)
Limited studies report that patients receiving immunosuppressive therapy, including cyclosporin A (CsA), face muscle and/or tendon pathologies. The current study aimed (i) to investigate if CsA cause changes in the microscopic structure of striated m